Stay updated on PLACARD Trial: CXD101 + Pembrolizumab in DLBCL

Sign up to get notified when there's something new on the PLACARD Trial: CXD101 + Pembrolizumab in DLBCL page.
Latest website image capture
Clouds background image

Latest updates to the PLACARD Trial: CXD101 + Pembrolizumab in DLBCL page

  1. Check
    6 days ago
    Change Detected
    Summary
    The site revision label in the footer changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T16:23:36.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The study page displays a 403 Forbidden message and a Home link in place of the study record.
    Difference
    0.5%
    Check dated 2026-10-03T16:13:43.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error instead of showing the study record content, indicating that access to the record is blocked. The surrounding site chrome remains, but the study details cannot be viewed.
    Difference
    19%
    Check dated 2026-09-19T21:59:55.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The Study Details page shows a new revision identifier (v3.6.6) replacing the prior v3.6.5, indicating a new build of the page.
    Difference
    0.1%
    Check dated 2026-08-29T18:39:15.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.4 to v3.6.5, signaling a minor update to the page's version. This update does not appear to change the trial details or content.
    Difference
    0.1%
    Check dated 2026-08-08T10:45:56.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    The revision tag on the page was updated from v3.6.3 to v3.6.4, indicating a minor administrative update to the page's revision history. There are no changes to study content or user-facing features.
    Difference
    0.1%
    Check dated 2026-07-25T06:26:33.000Z thumbnail image

Stay in the know with updates to PLACARD Trial: CXD101 + Pembrolizumab in DLBCL

Enter your email address, and we'll notify you when there's something new on the PLACARD Trial: CXD101 + Pembrolizumab in DLBCL page.